MASLD Research Center

MASLD Research Center @ UCSD

[Rohit Loomba @DrLoomba]

Bittersweet moment four our former students and now clinical research coordinators @MASLDResearch leaving and going to medical school! Couldn’t be more proud of them and love being able to play a small role in mentoring future generations of doctors 🙏 @AASLDtweets @pattymaysent

[MASLD Research Center @MASLDResearch]

Great discussions at the UCSD GI and Hepatology 17th Annual Research Retreat. Team members from the MASLD Research Center presented their work. @UCSD_GI @MonicaTincopa @AjmeraVeeral @LuisAntonioDiaz @DrLoomba

[Mónica Tincopa MD MSc DABOM @MonicaTincopa]

And just like that…
The time you do a Meet the Professor session on #NITs & therapeutics in #MASLD & #MASH @DDWMeeting with your former fellowship director.

Great session discussing diagnosis, risk stratification & treatment🙌

[MASLD Research Center @MASLDResearch]

As #DDW2026 kicks off, we’re proud to highlight our @UCSD_GI team presenting oral and poster sessions. Grateful for the collaboration and innovation that made this possible. Looking forward to an inspiring conference!#MASLD @MASLDResearch @DrLoomba

[Luis Antonio Díaz, MD @LuisAntonioDiaz]

1/ New review in @HepCommJournal by @PojsakornDan : The global epidemiology of alcohol-associated liver disease (ALD).
ALD is one of the most preventable causes of liver-related death worldwide — and the burden is set to surge.
A thread on what every clinician should know. 🧵

[Rohit Loomba @DrLoomba]

The future of hepatology: Preventing liver disease together with the public, scientists and artificial intelligence - JHEP Reports https://t.co/S8aP0IQuiH

[Daniel Huang @DrHuangDQ]

Advances in genomic discovery are bringing precision medicine closer to the bedside.

In @AGA_Gastro, we explore the promise and pitfalls of genetics and emerging personalized therapeutics in hepatology.

@AjmeraVeeral, V Chen, R Reddy @AmerGastroAssn

https://t.co/d9tZaQ4Ith

[Cell Metabolism @Cell_Metabolism]

New! Online now: The many pathways driving liver inflammation in MASH https://t.co/C7lnXNsiL2

[Luis Antonio Díaz, MD @LuisAntonioDiaz]

1/6 🧵 In patients with ALD referred for early LT: cardiometabolic risk factors (CMRF) matter. In this multicentre cohort, CMRFs were linked to a lower chance of hepatic recompensation after referral. #LiverTwitter @UCSD_GI @MASLDResearch @AjmeraVeeral @DeepikaDevuniMD

[Rohit Loomba @DrLoomba]

Our review on RLSE in MASH -Noninvasive surrogate endpoints of adverse outcomes,... : Hepatology https://t.co/U4Vx2vvhVy @AASLDtweets @EASLnews @BavenoCoop @APASLnews @INASL_Liver @QAnstee @VWSWong @AparnaGoelMD

[Rohit Loomba @DrLoomba]

Had a brilliant day as a visiting professor at PGIMER Chandigarh- thanks to @ajay_duseja for hosting me! Really enjoyed the research presentations by fellows & ward rounds followed by evening liver society forum! @drnipunverma @MASLDResearch @AASLDPresident @EASLnews @UCSDHealth

[Kriti Soni @kritisoni50]

Great CME hosted by Department of Hepatology, @pgichd.

Insightful discussion on recent advances in MASLD by @DrLoomba
Always inspiring to see the impactful work being led by @ajay_duseja .

As a trainee, grateful for the opportunity to learn from leaders in the field.

@drsuniltaneja @atulsachdeva @drnipunverma @drbabupgi

[American Gastroenterological Association (AGA) @AmerGastroAssn]

A new international consensus published in @AGA_Gastro establishes a unified framework for diagnosing and staging liver disease in α-1 antitrypsin deficiency.

Read more here: https://t.co/jEfPyqus87

@DrLoomba @MattiasMandorf1 @AleksanderKrag @PaulYKwo

[Rohit Loomba @DrLoomba]

Congratulations @f_tavaglione at @MASLDResearch @UCSD_GI for a fantastic paper- great to collaborate with @hanneshgstrm @EASLnews @AASLDtweets @AASLDPresident @AmerGastroAssn @AGA_Gastro
https://t.co/YYokJwiA7M

[Rohit Loomba @DrLoomba]

Factors associated with protection from MASLD in type 2 diabetes: A prospective study integrating longitudinal MRI/MRE and stable isotope tracing https://t.co/iGM2HVnwS2 @f_tavaglione nice paper! @AASLDtweets @EASLnews @MASLDResearch @UCSD_GI @UCSDHealth @AmerGastroAssn

[UC San Diego Health @UCSDHealth]

#ColorectalCancer is increasing among younger adults, making awareness & early screening more important than ever. Rohit Loomba, MD, #UCSDHealth, joined @CBS8 to discuss why screening matters, plus the key signs and symptoms you shouldn’t ignore.@DrLoomba https://t.co/rWLmerkBgN

[Rohit Loomba @DrLoomba]

Clinical utility of a 50% and 30% decline in MRI-PDFF in predicting fibrosis improvement in metabolic dysfunction-associated steatohepatitis - CGH https://t.co/i7gCTzmMGn

[Rohit Loomba @DrLoomba]

Our new paper on comparative efficacy of MASH therapies in cirrhosis- FGF-21, and combination therapies may be useful in reversing MASH cirrhosis-
@AASLDtweets @EASLnews @DrHuangDQ @MASLDResearch @UCSD_GI
Alimentary Pharmacology & Therapeutics | https://t.co/GQZqKLc1NM

[Rohit Loomba @DrLoomba]

Tonight talking about MASH including new treatments- ⁦@AjmeraVeeral⁩ in San Diego kickstarting with natural history and NITs in MASH ⁦@AASLDtweets⁩ ⁦@EASLnews⁩ ⁦@UCSDHealth⁩ ⁦@CLDFoundation⁩ - 60 registrations and a waiting list